aminocaproic acid has been researched along with Morbid Obesity in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenway, FL | 1 |
| Liu, Z | 1 |
| Yu, Y | 1 |
| Caruso, MK | 1 |
| Roberts, AT | 1 |
| Lyons, J | 1 |
| Schwimer, JE | 1 |
| Gupta, AK | 1 |
| Bellanger, DE | 1 |
| Guillot, TS | 1 |
| Woltering, EA | 1 |
1 other study available for aminocaproic acid and Morbid Obesity
| Article | Year |
|---|---|
An assay to measure angiogenesis in human fat tissue.
Topics: Aminocaproic Acid; Angiogenesis Modulating Agents; Biological Assay; Fibrinogen; Humans; Neovascular | 2007 |